Gilead starts Phase I trial of inhaled version of Covid-19 drug remdesivir July 13, 2020 Auto Bot BioPharma, biopharma nl, California, Foster City, Gilead Sciences, remdesivir, SARS-CoV-2 0 The study is enrolling 60 healthy volunteers aged 18-45, but the company hopes it will form the basis of trials of the drug as an outpatient treatment for patients who do not require hospitalization. Remdesivir is currently administered via IV.